Medicine and Dentistry
Respiratory Syncytial Virus
100%
Morbidity
50%
Kidney Graft
50%
Adenoviridae
50%
Immunosuppressive Treatment
50%
Prophylaxis
50%
Diagnosis
50%
Influenza Virus
50%
Adenovirus Infection
50%
Kidney Transplantation
50%
Antiinfective Agent
50%
Influenza
50%
Graft Survival
50%
Respiratory Syncytial Virus Infection
50%
Mortality
50%
Patient
50%
Therapeutic Procedure
50%
INIS
populations
100%
kidneys
100%
viruses
100%
adenovirus
100%
patients
50%
transplants
50%
mortality
50%
grafts
50%
immunosuppression
50%
morbidity
50%
influenza
50%
prophylaxis
50%
influenza viruses
50%
Immunology and Microbiology
Adenoviridae
100%
Respiratory Virus
100%
Morbidity
50%
Transplantation
50%
Influenza
50%
Kidney Transplantation
50%
Human Respiratory Syncytial Virus
50%
Mortality
50%
Survival
50%
Kidney
50%
Immunosuppression
50%
Influenza Virus
50%
Pharmacology, Toxicology and Pharmaceutical Science
Respiratory Virus
100%
Morbidity
50%
Antiinfective Agent
50%
Mortality
50%
Adenoviridae
50%
Influenza
50%
Adenovirus Infection
50%
Respiratory Syncytial Virus Infection
50%
Biochemistry, Genetics and Molecular Biology
Adenoviridae
100%
Respiratory Virus
100%
Morbidity
50%
Human Respiratory Syncytial Virus
50%
Mortality
50%
Survival
50%